FTRE

#2533
Fortrea Holdings Inc. Common Stock
9.59 USD
+2.24%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
9.59
9.59
1年のレンジ
3.97
18.67
1日の変化
+2.24%
月次変化
+1.48%
6か月変化
-0.62%
1年の変化
+80.94%
以前の終値
9.38
始値
9.59
Bid
Ask
安値
9.59
High
9.59
ボリューム
98
チャート全体を表示

Financials

概要 明細書 統計
期次 年次
  • Market Capitalization 896.66 M
  • Employee 14 K
  • Founded 2023
  • CEO Paul R. N. Kirchgraber
  • Website www.fortrea.com
  • Headquarter North Carolina, United States
  • FIGI BBG01GZF9VY6
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.6
売上高対価格比率
—

Fortrea Holdings Inc

Fortrea Holdings Inc. is an American contract research organization organized in Delaware and headquartered in Durham, North Carolina with operations in 90 countries. Its customers are primarily in the pharmaceutical, biotechnology, and medical device industries. Its primary business is handling all aspects of clinical trials including phase I through IV clinical trial management, clinical pharmacology, and post-approval services. It handles regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. It focuses on oncology, central nervous system and neurodegenerative, rare diseases, and cell and gene therapies. In the five years ending in 2023, it conducted more than 5,850 clinical trials involving over 1 million subjects. It also conducted over 600 studies for medical device companies. The company is one of the largest participants in the international primate trade and has been criticized for its animal testing practices, most specifically animal testing on non-human primates.

ニュース